Table 1.
Expression of miR-1254 and Smurf1 in human gastric cancer according to patients’ clinicopathological characteristics
Characteristics | Number | miR-1254 expression | p-value | Smurf1 expression | p-value | ||
---|---|---|---|---|---|---|---|
High group | Low group | High group | Low group | ||||
Age (years) | |||||||
<60 | 29 | 13 | 16 | 0.595 | 14 | 15 | 0.507 |
≥60 | 61 | 31 | 30 | 34 | 27 | ||
Gender | |||||||
Male | 42 | 23 | 19 | 0.297 | 23 | 19 | 0.799 |
Female | 48 | 21 | 27 | 25 | 23 | ||
Size (cm) | |||||||
<3 | 40 | 26 | 14 | 0.006* | 15 | 25 | 0.007* |
≥3 | 50 | 18 | 32 | 33 | 17 | ||
Histological type | |||||||
Well-moderately | 35 | 23 | 12 | 0.011* | 13 | 22 | 0.014* |
Poorly signet | 55 | 21 | 34 | 35 | 20 | ||
Stage | |||||||
I/II | 41 | 23 | 18 | 0.211 | 18 | 23 | 0.101 |
III/IV | 49 | 21 | 28 | 30 | 19 | ||
T grade | |||||||
T1+T2 | 34 | 20 | 14 | 0.142 | 16 | 18 | 0.353 |
T3+T4 | 56 | 24 | 32 | 32 | 24 | ||
Lymph node metastasis | |||||||
Absent (N0) | 37 | 25 | 12 | 0.003* | 14 | 23 | 0.014* |
Present (N1–N3) | 53 | 19 | 34 | 34 | 19 |
Clinicopathological results were compared using Pearson χ2 tests
*p < 0.05 statistically significant difference